Parenteral ascorbate is beneficial in ovarian cancer therapy.
D061605:Administration, Intravenous; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D001205:Ascorbic Acid